|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.5 EUR | +2.01% |
|
+1.96% | +0.89% |
| Apr. 26 | BioMérieux: share price rises, analyst remains Buy | CF |
| Apr. 26 | BIOMÉRIEUX : Berenberg raises its target | CF |
bioMérieux S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 3,674.7 million compared to EUR 3,589.1 million a year ago. Net income was EUR 357.6 million compared to EUR 452.4 million a year ago.
Basic earnings per share from continuing operations was EUR 3.03 compared to EUR 3.84 a year ago. Diluted earnings per share from continuing operations was EUR 3.01 compared to EUR 3.82 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.89% | 12.8B | |
| -10.29% | 7.61B | |
| +1.78% | 5.41B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.29B | |
| +12.21% | 2.73B | |
| -16.13% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
BIOMÉRIEUX 
